{"id":1034906,"date":"2012-06-11T21:13:12","date_gmt":"2012-06-11T21:13:12","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/gene-inactivation-drives-spread-of-melanoma.php"},"modified":"2024-08-17T15:40:58","modified_gmt":"2024-08-17T19:40:58","slug":"gene-inactivation-drives-spread-of-melanoma","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-medicine\/gene-inactivation-drives-spread-of-melanoma.php","title":{"rendered":"Gene inactivation drives spread of melanoma"},"content":{"rendered":"<p><p>    ScienceDaily (June 11, 2012)  Why do    some cancers spread rapidly to other organs and others don't    metastasize? A team of UNC researchers led by Norman Sharpless,    MD, have identified a key genetic switch that determines    whether melanoma, a lethal skin cancer, spreads by metastasis.  <\/p>\n<p>    Treating melanoma is extremely challenging. The cancer spreads    rapidly and to sites in the body that are remote from the    original cancer site. Melanoma is the most deadly form of skin    cancer, and advanced melanoma kills more than 8600 Americans    each year. It is the most common form of cancer in young    adults, aged 25-29 and the incidence of people under 30    developing melanoma is increasing fast -- more than 50 percent    in young women since 1980.  <\/p>\n<p>    In a paper published June 11 in the journal Cancer    Cell, a team from UNC Lineberger Comprehensive Cancer    Center demonstrates that inactivating a gene called LKB1 (or    STK11) causes non-aggressive melanoma cells to become highly    metastatic when tested in a variety of models using tumors from    humans and mice. While Sharpless and his colleagues showed a    role for LKB1 inactivation in lung cancer metastasis, the    effects of LKB1 loss on melanoma spread is even more dramatic.  <\/p>\n<p>    \"Although we are not totally certain how LKB1 loss promotes    metastasis in multiple cancer types, one important effect is    the loss of LKB1 starts a chain reaction, activating a family    of proteins called SRC kinases, which are known to drive    metastasis,\" said Sharpless, who is associate director for    translational research at UNC Lineberger.  <\/p>\n<p>    \"Loss of LKB1 occurs in about 30 percent of lung cancer and 10    percent of melanoma, and ongoing studies at UNC and elsewhere    will determine if these LKB1 deficient tumors have a worse    prognosis. These data suggest LKB1 deficient cancers will be    more likely to metastasize, and therefore more likely to be    incurable.\"  <\/p>\n<p>    \"The work is exciting because the laboratory model reliably    replicates distant metastases, helping us better understand    what treatments may work for melanoma that has spread. While    several targeted drugs have recently been approved by the FDA    for metastatic disease, these targeted mutations don't indicate    whether the disease is likely to metastasize,\" said Stergios    Moschos, MD, clinical associate professor of    hematology\/oncology. Moschos works in the area of drug    development for melanoma but was not involved in this research    project.  <\/p>\n<p>    Other members of the research team from UNC-Chapel Hill include    Wenjin Liu, PhD; Kimberly Monahan, PhD; and Jessica Sorrentino,    BS, from the department of genetics; Adam Pfefferle, BS, and    Ryan Miller, MD, from the department of pathology and    laboratory medicine; Keefe Chan, PhD, David Roadcap, PhD, and    James Bear, PhD; from the department of cell and developmental    biology; David Ollila, MD, from the division of surgical    oncology and endocrine surgery; and Charles Perou, PhD, of the    departments of genetics and pathology and the Carolina Genome    Sciences Center. Dr. Miller, Bear, Ollila, and Perou are also    members of UNC Lineberger Comprehensive Cancer Center and Dr.    Bear is a Howard Hughes Medical Institute investigator.  <\/p>\n<p>    Kwok-Kin Wong, MD PhD, from the Dana-Farber Cancer Institute    and Harvard Medical School and Diego Castrillon, MD PhD, from    the University of Texas Southwestern Medical Center also    contributed to the finding.  <\/p>\n<p>    The research was funded by the National Cancer Institute and    the NCI's Mouse Model of Human Cancer Consortium (MMHCC), the    National Institute on Aging and the National Institute of    Environmental Health Sciences (all part of the National    Institutes of Health.  <\/p>\n<p>    Share this story on Facebook,    Twitter, and Google:  <\/p>\n<\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.sciencedaily.com\/releases\/2012\/06\/120611134053.htm\" title=\"Gene inactivation drives spread of melanoma\" rel=\"noopener\">Gene inactivation drives spread of melanoma<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> ScienceDaily (June 11, 2012) Why do some cancers spread rapidly to other organs and others don't metastasize? A team of UNC researchers led by Norman Sharpless, MD, have identified a key genetic switch that determines whether melanoma, a lethal skin cancer, spreads by metastasis. Treating melanoma is extremely challenging.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-medicine\/gene-inactivation-drives-spread-of-melanoma.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246858],"tags":[],"class_list":["post-1034906","post","type-post","status-publish","format-standard","hentry","category-gene-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1034906"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1034906"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1034906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1034906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1034906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1034906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}